https://www.selleckchem.com/products/hc-258.html
This is the first study to evaluate the feasibility and acceptability of light therapy to reduce fatigue in AYA patients receiving cancer-directed therapy. These findings demonstrate the feasibility and acceptability of the intervention and provide preliminary evidence of the potential benefits of BWL, which warrants further study in a confirmatory efficacy trial. ClinicalTrials.gov Identifier Number NCT02429063. This is the first study to evaluate the feasibility and acceptability of light therapy to reduce fatigue in AYA patients recei
Like
Comment
Share
